1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Autologous Stem Cell Therapy 1.2.3 Non-Stem Cell Therapy 1.3 Market by Application 1.3.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Cancer 1.3.3 Neurodegenerative Disorders 1.3.4 Cardiovascular Disease 1.3.5 Autoimmune Diseases 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Perspective (2016-2027) 2.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Growth Trends by Regions 2.2.1 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Historic Market Share by Regions (2016-2021) 2.2.3 Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Regions (2022-2027) 2.3 Autologous Stem Cell and Non-Stem Cell Based Therapies Industry Dynamic 2.3.1 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Trends 2.3.2 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Drivers 2.3.3 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Challenges 2.3.4 Autologous Stem Cell and Non-Stem Cell Based Therapies Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Revenue 3.1.1 Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Revenue (2016-2021) 3.1.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Players (2016-2021) 3.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue 3.4 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Concentration Ratio 3.4.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in 2020 3.5 Autologous Stem Cell and Non-Stem Cell Based Therapies Key Players Head office and Area Served 3.6 Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Product Solution and Service 3.7 Date of Enter into Autologous Stem Cell and Non-Stem Cell Based Therapies Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Autologous Stem Cell and Non-Stem Cell Based Therapies Breakdown Data by Type 4.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Historic Market Size by Type (2016-2021) 4.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Type (2022-2027) 5 Autologous Stem Cell and Non-Stem Cell Based Therapies Breakdown Data by Application 5.1 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Historic Market Size by Application (2016-2021) 5.2 Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2016-2027) 6.2 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type 6.2.1 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021) 6.2.2 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027) 6.2.3 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2027) 6.3 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application 6.3.1 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021) 6.3.2 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027) 6.3.3 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2027) 6.4 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country 6.4.1 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2016-2021) 6.4.2 North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2016-2027) 7.2 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type 7.2.1 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021) 7.2.2 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027) 7.2.3 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2027) 7.3 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application 7.3.1 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021) 7.3.2 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027) 7.3.3 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2027) 7.4 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country 7.4.1 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2016-2021) 7.4.2 Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2016-2027) 8.2 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type 8.2.1 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2027) 8.3 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application 8.3.1 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2027) 8.4 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region 8.4.1 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2016-2027) 9.2 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type 9.2.1 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021) 9.2.2 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027) 9.2.3 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2027) 9.3 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application 9.3.1 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021) 9.3.2 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027) 9.3.3 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2027) 9.4 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country 9.4.1 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2016-2021) 9.4.2 Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (2016-2027) 10.2 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type 10.2.1 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2027) 10.3 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application 10.3.1 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2027) 10.4 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country 10.4.1 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Fibrocell Science, Inc. 11.1.1 Fibrocell Science, Inc. Company Details 11.1.2 Fibrocell Science, Inc. Business Overview 11.1.3 Fibrocell Science, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction 11.1.4 Fibrocell Science, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) 11.1.5 Fibrocell Science, Inc. Recent Development 11.2 Vericel Corporation 11.2.1 Vericel Corporation Company Details 11.2.2 Vericel Corporation Business Overview 11.2.3 Vericel Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction 11.2.4 Vericel Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) 11.2.5 Vericel Corporation Recent Development 11.3 Dendreon Corporation (Sanpower Group) 11.3.1 Dendreon Corporation (Sanpower Group) Company Details 11.3.2 Dendreon Corporation (Sanpower Group) Business Overview 11.3.3 Dendreon Corporation (Sanpower Group) Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction 11.3.4 Dendreon Corporation (Sanpower Group) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) 11.3.5 Dendreon Corporation (Sanpower Group) Recent Development 11.4 Caladrius Biosciences, Inc. 11.4.1 Caladrius Biosciences, Inc. Company Details 11.4.2 Caladrius Biosciences, Inc. Business Overview 11.4.3 Caladrius Biosciences, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction 11.4.4 Caladrius Biosciences, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) 11.4.5 Caladrius Biosciences, Inc. Recent Development 11.5 BrainStorm Cell Therapeutics 11.5.1 BrainStorm Cell Therapeutics Company Details 11.5.2 BrainStorm Cell Therapeutics Business Overview 11.5.3 BrainStorm Cell Therapeutics Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction 11.5.4 BrainStorm Cell Therapeutics Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) 11.5.5 BrainStorm Cell Therapeutics Recent Development 11.6 Regeneus Ltd. 11.6.1 Regeneus Ltd. Company Details 11.6.2 Regeneus Ltd. Business Overview 11.6.3 Regeneus Ltd. Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction 11.6.4 Regeneus Ltd. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) 11.6.5 Regeneus Ltd. Recent Development 11.7 Genzyme Corporation 11.7.1 Genzyme Corporation Company Details 11.7.2 Genzyme Corporation Business Overview 11.7.3 Genzyme Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction 11.7.4 Genzyme Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) 11.7.5 Genzyme Corporation Recent Development 11.8 Pluristem Therapeutics Inc 11.8.1 Pluristem Therapeutics Inc Company Details 11.8.2 Pluristem Therapeutics Inc Business Overview 11.8.3 Pluristem Therapeutics Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction 11.8.4 Pluristem Therapeutics Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) 11.8.5 Pluristem Therapeutics Inc Recent Development 11.9 U.S. Stem Cell, Inc 11.9.1 U.S. Stem Cell, Inc Company Details 11.9.2 U.S. Stem Cell, Inc Business Overview 11.9.3 U.S. Stem Cell, Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction 11.9.4 U.S. Stem Cell, Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) 11.9.5 U.S. Stem Cell, Inc Recent Development 11.10 TiGenix (Takeda) 11.10.1 TiGenix (Takeda) Company Details 11.10.2 TiGenix (Takeda) Business Overview 11.10.3 TiGenix (Takeda) Autologous Stem Cell and Non-Stem Cell Based Therapies Introduction 11.10.4 TiGenix (Takeda) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) 11.10.5 TiGenix (Takeda) Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Autologous Stem Cell Therapy Table 3. Key Players of Non-Stem Cell Therapy Table 4. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Regions (2016-2021) Table 8. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Regions (2022-2027) Table 10. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Trends Table 11. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Drivers Table 12. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Challenges Table 13. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Restraints Table 14. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Players (2016-2021) Table 16. Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies as of 2020) Table 17. Ranking of Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Autologous Stem Cell and Non-Stem Cell Based Therapies Product Solution and Service Table 21. Date of Enter into Autologous Stem Cell and Non-Stem Cell Based Therapies Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021) (US$ Million) Table 24. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Type (2016-2021) Table 25. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Application (2016-2021) Table 29. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021) (US$ Million) Table 32. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021) (US$ Million) Table 34. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size by Country (2022-2027) & (US$ Million) Table 61. Fibrocell Science, Inc. Company Details Table 62. Fibrocell Science, Inc. Business Overview Table 63. Fibrocell Science, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Product Table 64. Fibrocell Science, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million) Table 65. Fibrocell Science, Inc. Recent Development Table 66. Vericel Corporation Company Details Table 67. Vericel Corporation Business Overview Table 68. Vericel Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Product Table 69. Vericel Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million) Table 70. Vericel Corporation Recent Development Table 71. Dendreon Corporation (Sanpower Group) Company Details Table 72. Dendreon Corporation (Sanpower Group) Business Overview Table 73. Dendreon Corporation (Sanpower Group) Autologous Stem Cell and Non-Stem Cell Based Therapies Product Table 74. Dendreon Corporation (Sanpower Group) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million) Table 75. Dendreon Corporation (Sanpower Group) Recent Development Table 76. Caladrius Biosciences, Inc. Company Details Table 77. Caladrius Biosciences, Inc. Business Overview Table 78. Caladrius Biosciences, Inc. Autologous Stem Cell and Non-Stem Cell Based Therapies Product Table 79. Caladrius Biosciences, Inc. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million) Table 80. Caladrius Biosciences, Inc. Recent Development Table 81. BrainStorm Cell Therapeutics Company Details Table 82. BrainStorm Cell Therapeutics Business Overview Table 83. BrainStorm Cell Therapeutics Autologous Stem Cell and Non-Stem Cell Based Therapies Product Table 84. BrainStorm Cell Therapeutics Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million) Table 85. BrainStorm Cell Therapeutics Recent Development Table 86. Regeneus Ltd. Company Details Table 87. Regeneus Ltd. Business Overview Table 88. Regeneus Ltd. Autologous Stem Cell and Non-Stem Cell Based Therapies Product Table 89. Regeneus Ltd. Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million) Table 90. Regeneus Ltd. Recent Development Table 91. Genzyme Corporation Company Details Table 92. Genzyme Corporation Business Overview Table 93. Genzyme Corporation Autologous Stem Cell and Non-Stem Cell Based Therapies Product Table 94. Genzyme Corporation Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million) Table 95. Genzyme Corporation Recent Development Table 96. Pluristem Therapeutics Inc Company Details Table 97. Pluristem Therapeutics Inc Business Overview Table 98. Pluristem Therapeutics Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million) Table 99. Pluristem Therapeutics Inc Recent Development Table 100. U.S. Stem Cell, Inc Company Details Table 101. U.S. Stem Cell, Inc Business Overview Table 102. U.S. Stem Cell, Inc Autologous Stem Cell and Non-Stem Cell Based Therapies Product Table 103. U.S. Stem Cell, Inc Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million) Table 104. U.S. Stem Cell, Inc Recent Development Table 105. TiGenix (Takeda) Company Details Table 106. TiGenix (Takeda) Business Overview Table 107. TiGenix (Takeda) Autologous Stem Cell and Non-Stem Cell Based Therapies Product Table 108. TiGenix (Takeda) Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) & (US$ Million) Table 109. TiGenix (Takeda) Recent Development Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type: 2020 VS 2027 Figure 2. Autologous Stem Cell Therapy Features Figure 3. Non-Stem Cell Therapy Features Figure 4. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application: 2020 VS 2027 Figure 5. Cancer Case Studies Figure 6. Neurodegenerative Disorders Case Studies Figure 7. Cardiovascular Disease Case Studies Figure 8. Autoimmune Diseases Case Studies Figure 9. Others Case Studies Figure 10. Autologous Stem Cell and Non-Stem Cell Based Therapies Report Years Considered Figure 11. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Regions: 2020 VS 2027 Figure 14. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Regions (2022-2027) Figure 15. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Players in 2020 Figure 16. Global Top Autologous Stem Cell and Non-Stem Cell Based Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autologous Stem Cell and Non-Stem Cell Based Therapies as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue in 2020 Figure 18. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Type (2016-2021) Figure 19. Global Autologous Stem Cell and Non-Stem Cell Based Therapies Revenue Market Share by Type (2022-2027) Figure 20. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type (2016-2027) Figure 22. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application (2016-2027) Figure 23. North America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Country (2016-2027) Figure 24. United States Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type (2016-2027) Figure 28. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application (2016-2027) Figure 29. Europe Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Country (2016-2027) Figure 30. Germany Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type (2016-2027) Figure 38. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application (2016-2027) Figure 39. Asia-Pacific Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Region (2016-2027) Figure 40. China Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type (2016-2027) Figure 48. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application (2016-2027) Figure 49. Latin America Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Country (2016-2027) Figure 50. Mexico Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Type (2016-2027) Figure 54. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Application (2016-2027) Figure 55. Middle East & Africa Autologous Stem Cell and Non-Stem Cell Based Therapies Market Share by Country (2016-2027) Figure 56. Turkey Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Fibrocell Science, Inc. Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) Figure 60. Vericel Corporation Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) Figure 61. Dendreon Corporation (Sanpower Group) Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) Figure 62. Caladrius Biosciences, Inc. Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) Figure 63. BrainStorm Cell Therapeutics Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) Figure 64. Regeneus Ltd. Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) Figure 65. Genzyme Corporation Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) Figure 66. Pluristem Therapeutics Inc Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) Figure 67. U.S. Stem Cell, Inc Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) Figure 68. TiGenix (Takeda) Revenue Growth Rate in Autologous Stem Cell and Non-Stem Cell Based Therapies Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

Fibrocell Science, Inc. Vericel Corporation Dendreon Corporation (Sanpower Group) Caladrius Biosciences, Inc. BrainStorm Cell Therapeutics Regeneus Ltd. Genzyme Corporation Pluristem Therapeutics Inc U.S. Stem Cell, Inc TiGenix (Takeda)